Temporada, Cemarmimi .
HRN: 26-17-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/12/2024
12/18/2024
IVT
900mg
Q8hrs
Post Op Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes